Skip to content

Gross Profit at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$7.2M-30.0%
PTH
Pelthos Therapeutics Inc.PTHS
$9.23M
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$95.61M+67.7%
HRO
HarrowHROW
$27.05M-16.3%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$134.92M+9.2%
VAT
InnovateVATE

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's gross profit?
Journey Medical Corporation (DERM) reported gross profit of $9.74M in Q1 2026.
How has Journey Medical Corporation's gross profit changed year-over-year?
Journey Medical Corporation's gross profit increased by 16.7% year-over-year, from $8.35M to $9.74M.
What is the long-term trend for Journey Medical Corporation's gross profit?
Over 4 years (2021 to 2025), Journey Medical Corporation's gross profit has grown at a 7.2% compound annual growth rate (CAGR), from $31.05M to $40.93M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.